U.S. markets closed

Top Ranked Momentum Stocks to Buy for August 29th

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 29th:

CVS Health Corporation (CVS): This healthcare company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.

CVS Health Corporation Price and Consensus

CVS Health Corporation Price and Consensus

CVS Health Corporation price-consensus-chart | CVS Health Corporation Quote

CVS Health’s shares gained 6.7% over the last one month more than S&P 500’s decline of 3.2%. The company possesses a Momentum Score of A.

CVS Health Corporation Price

CVS Health Corporation Price

CVS Health Corporation price | CVS Health Corporation Quote

ACADIA Pharmaceuticals Inc. (ACAD): This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.

ACADIA Pharmaceuticals Inc. Price and Consensus

ACADIA Pharmaceuticals Inc. Price and Consensus

ACADIA Pharmaceuticals Inc. price-consensus-chart | ACADIA Pharmaceuticals Inc. Quote

ACADIA Pharmaceuticals’ shares gained 14.7% over the last one month. The company possesses a Momentum Score of B.

ACADIA Pharmaceuticals Inc. Price

ACADIA Pharmaceuticals Inc. Price

ACADIA Pharmaceuticals Inc. price | ACADIA Pharmaceuticals Inc. Quote

GMS Inc. (GMS): This distributor of construction products has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

GMS Inc. Price and Consensus

GMS Inc. Price and Consensus

GMS Inc. price-consensus-chart | GMS Inc. Quote

GMS’ shares gained 17.1% over the last one month. The company possesses a Momentum Score of A.

GMS Inc. Price

GMS Inc. Price

GMS Inc. price | GMS Inc. Quote

The Procter & Gamble Company (PG): This consumer goods company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.

Procter & Gamble Company (The) Price and Consensus

Procter & Gamble Company (The) Price and Consensus

Procter & Gamble Company (The) price-consensus-chart | Procter & Gamble Company (The) Quote

Procter & Gamble’s shares gained 4.5% over the last one month. The company possesses a Momentum Score of B.

Procter & Gamble Company (The) Price

Procter & Gamble Company (The) Price

Procter & Gamble Company (The) price | Procter & Gamble Company (The) Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Procter & Gamble Company (The) (PG) : Free Stock Analysis Report
 
GMS Inc. (GMS) : Free Stock Analysis Report
 
CVS Health Corporation (CVS) : Free Stock Analysis Report
 
ACADIA Pharmaceuticals Inc. (ACAD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research